Caption Management’s Filana Therapeutics FLNA Stock Holding History

Caption Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-600	Closed	-$21.6K	–	1658
2022 Q3	$25K	Buy	+600	New	+$16.2K	﹤0.01%	1415
2021 Q3	–	Sell	-45,000	Closed	-$3.76M	–	1763
2021 Q2	$3.85M	Buy	+45,000	New	+$2.41M	0.05%	442
2020 Q3	–	Sell	-33,202	Closed	-$103K	–	1227
2020 Q2	$103K	Buy	+33,202	New	+$151K	﹤0.01%	834

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Caption Management's FLNA Position: Q4 2022 in Review

Caption Management sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 600 shares — an estimated $21.6K sold.

Caption Management first reported a position in FLNA in Q2 2020 and held it in 3 quarters. The position peaked at $3.85M in Q2 2021. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

Caption Management reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
Caption Management sold 600 Filana Therapeutics shares in Q4 2022, an estimated $21.6K.
Caption Management first reported a position in Filana Therapeutics in Q2 2020 and held it in 3 quarters.
Caption Management's Filana Therapeutics position peaked at $3.85M in Q2 2021.
153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.